In Depth 12 Oct 2023 Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated? …to counter these diseases? Immunometabolism, an emerging field in therapeutics, aims to rein in autoimmunity altogether. According to Neil Weir, chief executive officer (CEO) of British biotech Sitryx, there are… October 12, 2023 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Dec 2023 A gene editing milestone: The FDA approves CASGEVY, the first CRISPR-based therapy …Pharmaceuticals, told Labiotech in a previous article about how gene therapy could offer promise for treating sickle cell disease. He continued to explain: “And there’s a small number of people… December 6, 2023 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 18 Jan 2024 GLP-1 agonists: what’s the hype about? …to double this year, according to J.P. Morgan Research. What GLP-1 means for the biotech industry At one point last year, these drugs sparked a buying spree, to the extent… January 18, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Oct 2022 Spinoff Biohaven launches with $258M and “incredible pipeline” …ODT (rimegepant), the leading novel calcitonin gene-related peptide (CGRP) receptor antagonist for the treatment of migraine in adults and the first and only therapy that both treats and prevents migraine… October 4, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2022 Taiwan-based Anyong Biotechnology first to employ seafood stem-cell freezing Anyong Biotechnology is the first company in its region to use the most advanced freezing technology in Asia, it was announced today (September 19). The aquatic food processing company based… September 19, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Startup Scout 10 Nov 2022 ResQ Biotech is using bacteria to discover Alzheimer’s treatments Protein misfolding underlies many incurable conditions such as Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). The Greek startup ResQ Biotech is harnessing bacteria to test potential peptide treatments for these… November 10, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2023 Stemline Therapeutics’ breast cancer treatment approved …data is consistent with the other endocrine therapies. Most of the adverse events (AEs), including nausea and musculoskeletal pain, were grade 1 and 2. No hematological safety signal was observed… January 31, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Opinion 16 Jul 2019 The Business of Biotech: What to Do When the S*#t Hits the Fan From CEO-itis to FDA-itis, the path of a biotech company is never dull. Whether the oft-repeated saying, “may you live in interesting times,” is a blessing or a curse depends… July 16, 2019 - 5 minutesmins - By Antoine Papiernik Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2023 2023 life sciences industry trends: adopting a digital-first mindset …nearly all key business capabilities, from early research to post-marketing pharmacovigilance. Smaller biotech organizations can also leverage the cloud to scale without drastically increasing spending. ● Automation: Automation enables pharmacovigilance… January 11, 2023 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jun 2022 Eye inflammation leads to FDA partial clinical hold on Nuvation Bio solid tumor study …said it proactively paused enrolment of new patients in order to further assess these adverse events with investigators and uveitis experts, and also reached out to the FDA for guidance… June 27, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jun 2023 Med-Life Discoveries to start rare pediatric disease trial …disease that is caused by mutations in any one of several genes that prevents the biosynthesis of a critical class of phospholipids called plasmalogens. The lack of these lipids in… June 9, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 7 Mar 2024 Can AbbVie’s legacy live beyond its once best-selling drug Humira? …recently, although it has been a bumpy ride. Humira patent expiration: catalyst for biosimilar revolution in Europe In Europe, Humira’s patent expired in 2018, which gave way to other biotechs… March 7, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email